Business

The Alzheimer's Disease Data Initiative is accepting applications for a $1 million first prize for agentic AI Alzheimer's research.

Dr. Deepti Pandita, UC Irvine Health CMIO & VP of Clinical Informatics, says that "if you don't have governance, anything can fall apart," and discusses the need to engage a diverse multi-stakeholder group to vet every AI project that is deployed.

The acquisition expands Teladoc's specialist network and presence in the region, while the company navigates ongoing financial challenges.

CredAlliance aims to eliminate duplication of the credentialing process for providers.

The financing comes on top of the company's $900 million annual research and development investment in the U.S.

The company plans to launch the first version of its AI Advocate tool, aimed at helping patients manage and guide their overall healthcare, in the third quarter of this year.

The company's CEO defended its feature as a wellness tool under the 21st Century Cures Act, combating the FDA’s claim that it qualifies as a regulated medical device.

Kenrick Cato, nurse scientist, pediatric data and analytics, Children's Hospital of Philadelphia, says that nurses are excited about AI but are cautious and while they want help from AI, they don't want AI to do their job.

The alliance aims to benefit patients with chronic conditions and allow real-time interoperability among healthcare providers, pharmacies and payers.

The company will use the funds to expand its technology offerings and nationwide partnerships.